Skip to main content

and
  1. No Access

    Article

    Regarding: A global anti-B cell strategy combining obinutuzumab and daratumumab in severe pediatric nephrotic syndrome

    Alan Majeranowski, Marcin Okrój in Pediatric Nephrology (2021)

  2. Article

    Open Access

    Are official confirmed cases and fatalities counts good enough to study the COVID-19 pandemic dynamics? A critical assessment through the case of Italy

    As the COVID-19 outbreak is develo** the two most frequently reported statistics seem to be the raw confirmed case and case fatalities counts. Focusing on Italy, one of the hardest hit countries, we look at ...

    Krzysztof Bartoszek, Emanuele Guidotti, Stefano Maria Iacus in Nonlinear Dynamics (2020)

  3. Article

    Open Access

    Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics

    Anti-CD20 monoclonal antibodies (mAbs) rituximab and ofatumumab are potent activators of the classical complement pathway, and have been approved for the treatment of B-cell malignancies. However, complement e...

    Anna Felberg, Aleksandra Urban, Anna Borowska in Cancer Immunology, Immunotherapy (2019)

  4. Article

    Open Access

    Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus

    In the present study, we sought to evaluate the complement activation product C4d as a marker for lupus nephritis in systemic lupus erythematosus (SLE).

    Myriam Martin, Karolina I. Smoląg, Albin Björk in Arthritis Research & Therapy (2017)

  5. Article

    Open Access

    Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis

    The complement system has been implicated in pathogenesis of systemic sclerosis (SSc). The goal of the present study was to evaluate improved complement biomarkers in SSc.

    Marcin Okrój, Martin Johansson, Tore Saxne, Anna M. Blom in Arthritis Research & Therapy (2016)

  6. Article

    Open Access

    Testing the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis

    Autoantibodies termed C3-nephritic factor (C3NeF), which stabilize convertases of the alternative complement pathway, often stimulate autoinflammatory diseases. However, knowledge about analogous autoantibodie...

    Anna M. Blom, Fernando Corvillo, Michal Magda in Journal of Clinical Immunology (2016)

  7. Article

    The atypical pattern of cell death in B16F10 melanoma cells treated with TNP-470

    TNP-470 is an acknowledged anti-angiogenic factor, and was studied clinically as an anti-cancer drug. We previously reported on an additional property of this molecule: the intracellular generation of reactive...

    Marcin Okrój, Dorota Stawikowska, Ewa M. Słomińska in Cellular & Molecular Biology Letters (2006)